Search results for: 'biologics particul analyst'

15 Apr 2021  |  Europe  |  Market Research

Disruptive Technologies Will Propel the Scandinavian PPE Market

An Innovation Culture Driven by Customers' Focus on Quality and Performance Creates Future Growth Opportunities

Infographics

×

Personal protective equipment (PPE) is required at work sites with any type of physical, electrical, heat, or chemical hazard. PPE of 7 major categories (above-the-neck protection, respiratory protection, hand protection, protective clothing, foot protection, fall protection, and gas detection) protects a user against workplace injuries and illness...

Increasing air pollution, urbanization, and industrialization severely degrade air quality, which worsens when natural calamities such as wildfires occur. The spread of the SARS-CoV-2 virus (COVID-19 pandemic) and rising public awareness of the dangers of air pollution significantly accelerated the demand for air purification units in residential a...

The rest of the world (RoW) firefighting PPE market generated revenue of 802.8 million in 2023. Firefighters wrestle with occupational hazards, such as physical, electrical, heat, chemicals, biohazards, and airborne particulate matter. PPE safeguards firefighters against contaminants, debris, fire/heat, and chemicals. As such, increased awareness ...

23 Oct 2020  |  North America  |  Market Research

Access to New Therapy Areas to Drive Major Growth in the Global Biosimilars Market, 2020–2026

Outsourced Manufacturing of the Complex Third Wave of Biosimilars to Spark New Growth Opportunities

Infographics

×

Key Issues Addressed

In this research service, the Transformational Health team at Frost & Sullivan provides critical insights into the global biosimilar industry, highlighting the key growth opportunities, market revenue forecasts, and trends that will influence the industry with the emergence of the third wave of biosimilars. The global third-wave biosimilars market ...

19 Feb 2021  |  North America  |  Market Research

Regulatory and Infrastructure Reforms in India and China Catalyzing the Asian Specialty Generics Market

High Unmet Needs in Niche Oncology Indications will Drive Future Growth Potential

Infographics

×

Frost & Sullivans Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and c...

Respiratory diseases are on the rise globally due to various factors, including environmental ones. Obstructive lung diseases such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis are a huge burden on the global healthcare system. Existing therapies can only reduce the impact and provide short-term relief, but are not ca...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...